Literature DB >> 3497070

Specific antibody synthesis and biliary secretion by the rat liver after intestinal immunization with cholera toxin.

J Altorfer, S J Hardesty, J H Scott, A L Jones.   

Abstract

This study was designed to investigate the location, specificity, and significance of antibody-containing cells in the liver. After intestinal administration of cholera toxin, high numbers of specific antibody-containing cells appeared in the liver during the early priming period and after boosting. In contrast, a significant number of specific antibody-containing cells appeared in the lamina propria of the intestine only after boosting. In the liver, the specific antibody-containing cells were predominantly located in the sinusoidal region of zone 1 of the liver lobules. About 80% of the specific antibody-producing cells in the liver synthesized anticholera toxin antibody of the immunoglobulin A class. During the priming period, the concentration of immunoglobulin A anticholera toxin in bile paralleled the increase and decrease in the number of specific antibody-containing cells in the liver. Liver perfusion experiments indicated that during the priming period at least 70% of the biliary immunoglobulin A anticholera toxin antibody was synthesized within the liver, whereas 30% was synthesized in the liver after boosting. Thus, during the early immune response, the liver seems to be the major source for specific biliary antibody to intestinally administered cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497070     DOI: 10.1016/0016-5085(87)90917-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Further evidence that hepatic sources confer biliary antibody in the rat.

Authors:  G D Jackson; P G Hansen; B J Underdown
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  Mucosal immune response to cholera toxin in ageing rats. I. Antibody and antibody-containing cell response.

Authors:  D L Schmucker; C K Daniels; R K Wang; K Smith
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

3.  Intestinal immunisation with Escherichia coli protects rats against Escherichia coli induced cholangitis.

Authors:  B D Aagaard; M F Heyworth; A L Oesterle; A L Jones; L W Way
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Reduction in biliary IgA after burn injury. Role of diminished delivery via the thoracic duct and of enhanced loss from the systemic circulation.

Authors:  W A Cappeller; K J Bloch; R A Hatz; E A Carter; J Fagundes; D A Sullivan; P R Harmatz
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

5.  Antibody-secreting cell responses in the mouse liver.

Authors:  H Y Wu; M W Russell
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

6.  Appearance of IgG and IgA antibodies in human bile after tetanus toxoid immunization.

Authors:  P G Hansen; E J Hennessy; H Blake; R L Clancy; R Kamath; C Molenaar; A W Cripps; G D Jackson
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

7.  Effect of thermal injury in the rat on transfer of IgA protein into bile.

Authors:  P R Harmatz; E A Carter; D Sullivan; R A Hatz; R Baker; E Breazeale; K Grant; K J Bloch
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

8.  Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.

Authors:  B Haneberg; D Kendall; H M Amerongen; F M Apter; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.